What's breaking now, across thousands of outlets.
AstraZeneca said Friday that its recently approved breast cancer drug Etcamah failed a late-stage trial designed to support a label expansion into an earlier setting. Just last week, the FDA cleared the ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Hayden Panettiere died from an apparent overdose after consuming a lethal pill, suspected to contain oxycodone and fentanyl.
Meet Muthuri Kinyamu, the Nairobi entrepreneur whose fleet of wheelchair-accessible vehicles, BLS-trained driver-guides and disability-etiquette-trained staff is quietly transforming how Kenya's…
Definium Therapeutics reported results Monday for its third Phase 3 readout this year on its oral LSD candidate, called DT120, and is gearing up for an FDA submission.
The Veterinary Services Department of the Ministry of Food and Agriculture has commenced a nationwide campaign to provide free rabies vaccinations for 25,000 dogs and cats in identified high-risk…
Scholar Rock has won FDA approval for its drug treating a rare muscle-wasting disease, after facing delays due to a troubled manufacturing factory.
